Cingulate Correlations

CING Stock

USD 4.36 0.16 3.81%

The current 90-days correlation between Cingulate and Senti Biosciences is 0.13 (i.e., Average diversification). The correlation of Cingulate is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Cingulate Correlation With Market

Significant diversification

The correlation between Cingulate and DJI is 0.09 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate and DJI in the same portfolio, assuming nothing else is changed.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cingulate. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.

Moving together with Cingulate Stock

0.61	ELAN	Elanco Animal Health	Pair Corr
0.65	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.65	RDY	Dr Reddys Laboratories	Pair Corr
0.61	TAK	Takeda Pharmaceutical	Pair Corr
0.65	INAB	In8bio Inc	Pair Corr
0.71	REVB	Revelation Biosciences	Pair Corr
0.67	SIGA	SIGA Technologies	Pair Corr

Moving against Cingulate Stock

0.84	BHC	Bausch Health Companies	Pair Corr
0.79	GILD	Gilead Sciences	Pair Corr
0.74	EWTX	Edgewise Therapeutics	Pair Corr
0.63	BMY	Bristol Myers Squibb Sell-off Trend	Pair Corr
0.6	GANX	Gain Therapeutics	Pair Corr
0.53	ESPR	Esperion Therapeutics Buyout Trend	Pair Corr
0.47	WAT	Waters	Pair Corr
0.34	EBS	Emergent Biosolutions	Pair Corr
0.65	BSX	Boston Scientific Corp Sell-off Trend	Pair Corr
0.55	CPRX	Catalyst Pharmaceuticals	Pair Corr
0.46	ABT	Abbott Laboratories Sell-off Trend	Pair Corr
0.4	SMMT	Summit Therapeutics PLC	Pair Corr
0.32	MNMD	Mind Medicine	Pair Corr
0.32	APGE	Apogee Therapeutics,	Pair Corr

Related Correlations Analysis

	SABSW	SNTI	BLCM	HILS	AVTE	ADAG	ACRV	RZLT	ANTX
SABSW		-0.49	0.39	-0.32	0.79	0.11	-0.09	0.52	0.41	SABSW
SNTI	-0.49		-0.23	0.44	-0.66	0.24	0.4	-0.24	-0.25	SNTI
BLCM	0.39	-0.23		0.3	0.32	0.45	0.45	0.48	0.01	BLCM
HILS	-0.32	0.44	0.3		-0.44	0.31	0.52	-0.41	0.04	HILS
AVTE	0.79	-0.66	0.32	-0.44		-0.09	-0.25	0.5	0.41	AVTE
ADAG	0.11	0.24	0.45	0.31	-0.09		0.78	0.44	-0.1	ADAG
ACRV	-0.09	0.4	0.45	0.52	-0.25	0.78		0.28	-0.1	ACRV
RZLT	0.52	-0.24	0.48	-0.41	0.5	0.44	0.28		-0.05	RZLT
ANTX	0.41	-0.25	0.01	0.04	0.41	-0.1	-0.1	-0.05		ANTX
	SABSW	SNTI	BLCM	HILS	AVTE	ADAG	ACRV	RZLT	ANTX

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

AVTE	+ 0.79	SABSW
ACRV	+ 0.78	ADAG
RZLT	+ 0.52	SABSW
ACRV	+ 0.52	HILS
RZLT	+ 0.5	AVTE
RZLT	+ 0.48	BLCM

High negative correlations

AVTE	- 0.66	SNTI
SNTI	- 0.49	SABSW
AVTE	- 0.44	HILS
RZLT	- 0.41	HILS
HILS	- 0.32	SABSW
ACRV	- 0.25	AVTE

Risk-Adjusted Indicators

There is a big difference between Cingulate Stock performing well and Cingulate Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Cingulate's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
SABSW	13.46	4.35	0.24	(7.33)	11.04	(23.35)	52.09	(24.13)	102.82
SNTI	3.20	(0.29)	0.00	(2.01)	0.00	0.00	7.04	(7.36)	29.17
BLCM	12.36	1.06	0.06	2.53	14.01	(18.85)	23.53	(20.00)	191.61
HILS	5.56	(0.23)	0.00	0.19	0.00	0.00	8.33	(7.89)	113.15
AVTE	2.45	0.45	0.18	0.57	2.04	(3.35)	5.58	(3.86)	19.11
ADAG	4.44	(0.25)	0.00	(0.78)	0.00	0.00	8.13	(9.52)	37.93
ACRV	2.87	(0.43)	0.00	(0.13)	0.00	0.00	7.66	(7.65)	22.84
RZLT	2.78	(0.03)	0.01	0.09	3.11	(3.21)	6.80	(5.54)	30.01
ANTX	1.86	0.19	0.06	0.34	1.86	(3.09)	3.73	(3.42)	28.03

Cingulate Corporate Executives

Elected by the shareholders, the Cingulate's board of directors comprises two types of representatives: Cingulate inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cingulate. The board's role is to monitor Cingulate's management team and ensure that shareholders' interests are well served. Cingulate's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cingulate's outside directors are responsible for providing unbiased perspectives on the board's policies.

	Jennifer CPA	Senior CFO	Profile
	Dr MBA	Executive COO	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC